Primary surgery with Dual Mobility Cup
DeviceHip joint replacement with a hip prosthesis including a Dual Mobility cup to replace the acetabular component.
NCT Number: NCT02062450
The purpose of this study is to demonstrate the performance and reliability of Tornier "Dual Mobility Cup" used during primary total hip replacement or hip replacement revision surgery at least 24 months post-insertion.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The PURPOSE of this study is to demonstrate the performance and reliability of the Tornier "Dual Mobility Cup" used during primary total hip replacement or hip replacement revision surgery at a minimum of 24 months post-implantation. The primary endpoint is to determine the dislocation rate observed during post-surgical follow-up. The secondary endpoints are to assess, in the short-term, the following: clinical performance on the basis of clinical scores and hip mobility; radiological performance, particularly in terms of positioning and fixation of the implant; as well as the reliability of the implantation of this acetabular cup on the basis of any complications observed
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hip joint replacement with a hip prosthesis including a Dual Mobility cup to replace the acetabular component.
Hip joint replacement with a hip prosthesis including a Dual Mobility cup to replace the acetabular component.
Time frame: 2-year postoperative
The primary safety outcome (implant dislocation) was assessed by a single question to the patients : Did you experience any implant dislocation since your surgery ? Positive answers were quantified.
Time frame: 2-year postoperative
The primary safety outcome (implant dislocation) was assessed by a single question to the patients : Did you experience any implant dislocation since your surgery ? Positive answers were quantified.
Time frame: 2-year postoperative
Implant survivorship criteria was assessed by investigators during patients visits : is the implanted device still in place 2 years after surgery ? Negative answers were quantified.
Time frame: 2 years postoperative
Postel-Merle-d'Aubigné (PMA) score is known since 1954 and is a very widespread mean of evaluating the clinical function of the hip by the physician.
It contains three items: pain, function and hip mobility, each noted on 6 points (0 is the worst possible score and 18 is the best possible score) :
Time frame: 2 years postoperative
The HOOS (Hip disability and Osteoarthritis Outcome Score) is a patient questionnaire evaluating patients' feelings about their operated hip. It consists of 40 questions divided into 5 subgroups: pain, symptoms, daily living, quality of life, sports and recreational activities. Each category is scored on 100 points, 0 being the worse outcome and 100 the best outcome.
Time frame: 2-year postoperative
The HARRIS score is a physician questionnaire assessing hip pain, function and mobility on a total of 100 points, 100 being the maximum score. A result between 90 and 100 points is considered "excellent", between 80 and 90 "good", between 70 and 80 "mediocre" and less than 70 "poor".
Stryker Trauma and Extremities
Industry
Multicentre, Observational Study Evaluating the Clinical and Radiological Outcomes of Hip Arthroplasty Using the Dual Mobility Cup
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06632301
Arthritis, Bone Diseases
Hanover, Germany
View Trial DetailsNCT03396224
Congenital Abnormalities, Congenital Hip Dysplasia
Woluwe-Saint-Lambert, Brussels Capital, Belgium
View Trial DetailsNCT03357445
Congenital Abnormalities, Congenital Hip Dysplasia
Caen, France
View Trial DetailsNCT05128500
Arthritis, Arthritis, Psoriatic
Hanover, Germany
View Trial Details